image: Inspired by traditional herbal decoction, this study shows that synergistic heating and stirring drive baicalin–berberine from metastable aggregates into ordered left-handed helical nanoribbons, enhancing gastrointestinal stability and prolonging the mean residence time of the bioactive component in vivo. The assembly promotes hepatic lipophagy and ameliorates fatty liver in mice, with its effects associated with AMPK–FoxO1–TFEB-related lysosomal regulation. This work provides experimental evidence for establishing a “process–structure–efficacy” relationship.
Credit: Haoqiang Zhao and co-authors, National Science Review (2026)
Traditional Chinese herbal decoction has been passed down for more than two millennia, yet “what actually happens during decoction” has long remained a scientific “black box.” In co-decoction systems, non-covalent self-assembly among components is widespread. Previous studies have mostly focused on identifying the existence of aggregates and characterizing their morphology, but rarely on how decoction processing affects the intrinsic evolution of aggregation states. The innovation of this work lies in shifting the research focus, for the first time, to decoction-induced “dynamic phase evolution.” The study systematically addresses how, in an enclosed aqueous phase with homogeneous chemical composition, macroscopic thermodynamic and hydrodynamic parameters couple to drive molecules from a low-energy-barrier metastable state to rearrange into a mesoscopic topological phase with specific supramolecular chirality. It further confirms that the structural robustness conferred by this phase evolution is precisely the physicochemical origin underlying differences in sustained gastrointestinal release after oral administration and in downstream lysosomal lipophagy pathways.
Using supramolecular chiral assembly as an entry point, the team investigated the classic herb pair Scutellaria baicalensis–Coptis chinensis, revealing the physicochemical essence of decoction-driven microscopic reorganization. The study found that heat and fluid shear generated by stirring during decoction can synergistically drive baicalin and berberine to spontaneously reorganize from low-order metastable aggregates into tightly ordered, left-handed helical nanoribbons. Notably, these two types of aggregates have identical chemical composition and molar ratio; merely through rearrangement of molecular packing, they exhibit distinctly different structural characteristics at the mesoscale.
Such mesostructural differences directly alter the in vivo fate and therapeutic performance of the drug after oral administration. The study provides evidence from three aspects:
(1) Greater structural stability and more sustained release. In continuous simulated gastrointestinal digestion experiments, the ordered nanoribbons showed superior structural stability, with significantly stronger resistance to dissociation than metastable aggregates, enabling steady and sustained release of bioactive components.
(2) Substantially prolonged in vivo residence time. Oral pharmacokinetic studies in rats showed that, owing to their superior structural robustness, the nanoribbons greatly extended the mean residence time (MRT) of the core component berberine to 23.06 hours, significantly longer than 15.87 hours in the ordinary metastable aggregate group.
(3) More pronounced improvement in fatty liver, with distinct mechanistic pathways. In mice with high-fat-diet-induced fatty liver, the nanoribbon group produced more obvious improvement in hepatic lipid deposition. Combined liver transcriptomic and metabolomic analyses showed that changes in the metastable aggregate group mainly involved the PPAR signaling pathway and pyrimidine metabolism, whereas the nanoribbon group involved FoxO signaling and lysosome-related pathways. Liver tissue protein assays suggested that the effect of the nanoribbons is associated with the AMPK–FoxO1–TFEB–lysosome axis; cell experiments further supported the involvement of lipophagy in their lipid-lowering effect.
This study converts heating and liquid flow in traditional decoction into controllable physicochemical parameters, establishing a “process control–mesostructure–efficacy” scientific chain in a two-component model. It provides a new dimension for studying how decoction and compatibility affect efficacy: beyond determining which components are extracted and in what amounts, one can also compare the states in which these components exist and how they are released in the body. By integrating intermolecular interactions, ordered hierarchical packing, and supramolecular chirality into a unified analytical framework, the work not only offers a new tool for precisely capturing efficacious condensed states in complex real decoctions in the future, but also opens a new path for promoting the scientific evaluation of traditional decoction processes and modern formulation innovation.
The work was supported by the National Natural Science Foundation of China (82304704, 81803793 and 52321006), the Beijing Natural Science Foundation (7242240) and the Fundamental Research Funds for the Central Universities (2023-JYB-JBQN-052 and 2026-JYB-JBRC-003).